<GlossaryTerm id="CDR0000798302"><TermName>VAdriaC</TermName><TermPronunciation>(VAY-dree-ak)</TermPronunciation><TermDefinition><DefinitionText>An abbreviation for a chemotherapy combination used to treat Ewing sarcoma and other sarcomas, such as mesenchymal chondrosarcoma. It includes the drugs vincristine sulfate, doxorubicin hydrochloride (Adriamycin), and cyclophosphamide. Also called VAdriaC regimen.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000798873" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;VAdriaC&quot;" language="en" id="_3"/><MediaLink ref="CDR0000798872" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;VAdriaC&quot;" language="es" id="_4"/><SpanishTermName>VAdriaC</SpanishTermName><SpanishTermDefinition><DefinitionText>Nombre de una quimioterapia combinada que se usa para el tratamiento del sarcoma de Ewing y otros sarcomas, como el condrosarcoma mesenquimatoso. Incluye los medicamentos sulfato de vincristina, clorhidrato de doxorrubicina (Adriamycin) y ciclofosfamida. También se llama régimen VAdriaC.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2019-05-23</DateFirstPublished></GlossaryTerm>
